v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net income $ 1,633,700,000 $ 847,600,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 755,200,000 850,300,000
Deferred income taxes 185,400,000 6,100,000
Share-based compensation expense related to equity incentive plans 126,500,000 163,200,000
Loss on settlement of debt 8,300,000 101,600,000
Amortization of debt discount 5,400,000 34,900,000
Amortization of debt issuance costs 7,100,000 9,200,000
Impairment of intangible assets 1,400,000 0
Other non-cash adjustment (1,800,000) (9,500,000)
Changes in operating assets and liabilities, excluding impact of acquisitions:    
(Increase) decrease in accounts receivable (102,400,000) 67,600,000
Increase in inventories (324,800,000) (105,000,000.0)
Increase in accounts payable and accrued liabilities 225,500,000 73,800,000
Change in other assets and liabilities 408,000,000.0 30,300,000
Change in income tax payable (16,000,000.0) 24,900,000
Net cash provided by operating activities 2,911,500,000 2,095,000,000
Cash flows from investing activities:    
Proceeds from sales of assets 400,000 12,200,000
Investments in other assets (75,600,000) (91,700,000)
Capital expenditures (373,500,000) (255,500,000)
Net cash used in investing activities (448,700,000) (335,000,000.0)
Cash flows from financing activities:    
Proceeds from issuance of senior notes 0 997,000,000.0
Repayment of senior notes 0 (1,000,000,000)
Payments on settlement of convertible debt (170,400,000) (359,800,000)
Deferred financing costs 0 (7,800,000)
Proceeds from sale of common stock 54,300,000 47,100,000
Tax payments related to shares withheld for vested RSUs (57,200,000) (66,900,000)
Repurchase of common stock (671,900,000) (166,000,000.0)
Payment of cash dividends (499,400,000) (363,000,000.0)
Capital lease payments (600,000) (600,000)
Net cash used in financing activities (2,491,300,000) (1,726,500,000)
Net (decrease) increase in cash and cash equivalents (28,500,000) 33,500,000
Cash and cash equivalents, and restricted cash at beginning of period 317,400,000 280,000,000.0
Cash and cash equivalents, and restricted cash at end of period 288,900,000 313,500,000
Revolving Credit Facility    
Cash flows from financing activities:    
Proceeds from borrowings on Revolving Credit Facility 4,021,000,000 2,947,000,000
Repayments of line of credit $ (5,167,100,000) $ (3,753,500,000)